Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Neurol ; 369: 114521, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37634695

ABSTRACT

As a common diffuse encephalopathy caused by sepsis, sepsis-associated encephalopathy (SAE) is closely associated with increased mortality, severe cognition dysfunction and increased cost of health care in patients of sepsis. Accumulating evidence suggests that the dura mater, the outermost meninges of the central nervous system (CNS), plays an important role in CNS immunity, especially with the discovery of meningeal lymphatic vessels (mLVs), as well as a plentiful array of resident or infiltrating immune cells harbored in the dura. Although these findings have significantly enhanced our understanding of the immune function of dura under both steady-state and pathological condition of CNS, whether and how the immune cells and mLVs within dura response to SAE still remains largely unexplored. Here, we established lipopolysaccharide (LPS) intraperitoneal injection-induced SAE model and examined the dural resident immune cells and mLVs. We analysed the histological change in dura by performing hematoxylin and eosin (H&E) and immunofluorescence staining. Results showed that systemic exposure to LPS induced neutrophils recruitment, exudation and gathering around the dural blood vessels. Moreover, resident macrophage altered its shape as well as location, and downregulated major histocompatibility (MHC) class II expression following LPS injection. We also found that LPS exposure induced dorsal meningeal lymphangiogenesis. Together, these findings collectively demonstrated that LPS-induced SAE can stimulate immune cells and mLVs within dura and provided more information about the immune response of the dura in sepsis.

2.
J Neurotrauma ; 36(12): 1949-1964, 2019 06 15.
Article in English | MEDLINE | ID: mdl-30543130

ABSTRACT

Axon retraction greatly limits functional recovery after spinal cord injury (SCI) and neuron polarization, which affects processes including axon formation and development, is a promising target for promoting axon regeneration. Increasing microtubule stability has been demonstrated to improve intrinsic axon regeneration processes and is critically related to endoplasmic reticulum (ER)-mitochondria interactions. We used real-time polymerase chain reaction, Western blotting, and immunofluorescence to screen a variety of natural compounds, and found that Loureirin B (LrB) effectively promoted neuron polarization and axon regeneration in vitro and in vivo. LrB significantly inhibited ER stress and thereby promoted mitochondrial functions by regulating mitochondrial fusion. Further, LrB reactivated the Akt/GSK-3ß pathway, which plays critical roles in cell survival and microtubule stabilization. Taken together, our results suggest that the effects of LrB on neuron regeneration involve the inhibition of ER stress-induced mitochondrial dysfunction and activation of the Akt/GSK-3ß pathway, which further promotes microtubule stabilization. LrB may therefore be a promising candidate for facilitating recovery following SCI.


Subject(s)
Axons/metabolism , Endoplasmic Reticulum Stress/physiology , Glycogen Synthase Kinase 3 beta/metabolism , Mitochondria/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Resins, Plant/pharmacology , Spinal Cord Injuries/metabolism , Animals , Axons/drug effects , Cells, Cultured , Endoplasmic Reticulum Stress/drug effects , Female , Mitochondria/drug effects , Nerve Regeneration/drug effects , Nerve Regeneration/physiology , Pregnancy , Rats , Rats, Sprague-Dawley , Resins, Plant/therapeutic use , Spinal Cord Injuries/drug therapy
3.
J Cell Mol Med ; 22(5): 2727-2738, 2018 05.
Article in English | MEDLINE | ID: mdl-29512938

ABSTRACT

Fibroblast growth factor 1 (FGF1) is thought to exert protective and regenerative effects on neurons following spinal cord injury (SCI), although the mechanism of these effects is not well understood. The use of FGF1 as a therapeutic agent is limited by its lack of physicochemical stability and its limited capacity to cross the blood-spinal cord barrier. Here, we demonstrated that overexpression of FGF1 in spinal cord following SCI significantly reduced tissue loss, protected neurons in the ventricornu, ameliorated pathological morphology of the lesion, dramatically improved tissue recovery via neuroprotection, and promoted axonal regeneration and remyelination both in vivo and in vivo. In addition, the autophagy and the expression levels of PRDX1 (an antioxidant protein) were induced by AAV-FGF1 in PC12 cells after H2 O2 treatment. Furthermore, the autophagy levels were not changed in PRDX1-suppressing cells that were treated by AAV-FGF1. Taken together, these results suggest that FGF1 improves functional recovery mainly through inducing PRDX1 expression to increase autophagy and anti-ROS activity after SCI.


Subject(s)
Autophagy , Fibroblast Growth Factor 1/therapeutic use , Peroxiredoxins/metabolism , Reactive Oxygen Species/metabolism , Recovery of Function , Spinal Cord Injuries/drug therapy , Spinal Cord Injuries/physiopathology , Animals , Autophagy/drug effects , Axons/drug effects , Axons/metabolism , Cell Polarity/drug effects , Cytoskeleton/drug effects , Cytoskeleton/metabolism , Dependovirus/genetics , Female , Fibroblast Growth Factor 1/pharmacology , Genetic Vectors/metabolism , Motor Activity/drug effects , Nerve Regeneration/drug effects , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , PC12 Cells , Rats , Rats, Sprague-Dawley , Recovery of Function/drug effects , Remyelination/drug effects , Spinal Cord Injuries/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...